Articles tagged "Liver transplantation"

2019 American Transplant Congress
Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation
G. Kelly¹, J. L. Pasko¹, E. Dewey², E. Maynard¹, S. L. Orloff¹, C. Enestvedt¹
¹Division of Abdominal Transplant, OHSU, Portland, OR, ²Department of General Surgery, OHSU, Portland, OR
*Purpose: The aim of this study was to determine whether intraoperative autologous transfusion in liver transplant patients with HCC affects the rate of recurrence.*Methods: We…
2019 American Transplant Congress
Access to Deceased Donor Liver Transplant for Candidates in Hawaii and Puerto Rico
A. M. Robinson¹, I. K. Kim², A. K. Mathur³, S. E. Rosas⁴
¹United Network for Organ Sharing, Richmond, VA, ²Cedars-Sinai Medical Center, Los Angeles, CA, ³Mayo Clinic Arizona, Phoenix, AZ, ⁴Joslin Diabetes Center, Harvard Medical School, Boston, MA
*Purpose: Hawaii and Puerto Rico comprise their own donor service areas (DSAs), HIOP and PRLL respectively. The liver programs in these locations serve populations mostly…
2019 American Transplant Congress
Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation
S. Nagai¹, M. Rizzari¹, Y. Muszkat², K. Collins¹, A. Yoshida¹, S. Jafri², M. Abouljoud¹
¹Transplant and Hepatobiliary Surgeryery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: Liver-intestine allocation is determined in the liver waitlist. This study aimed to evaluate effects of recent updates in liver allocation policy on waitlist outcomes…
2019 American Transplant Congress
Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells
A. A. Duizendstra¹, R. J. Knegt de¹, M. G. Betjes², M. P. Peppelenbosch¹, N. H. Litjens², J. Kwekkeboom¹
¹Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands, ²Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands
*Purpose: Lifelong treatment with immunosuppressive drugs (IS) to prevent graft rejection in transplant recipients is accompanied by side effects. Some recipients are considered to be…
2019 American Transplant Congress
Frailty Associated with Increased Rates of Acute Cellular Rejection within 3 Months after Liver Transplantation
L. Fozouni, A. Lebsack, Y. Mohamad, C. Freise, P. Stock, J. Lai
UCSF, San Francisco, CA
*Purpose: Frailty, a state of decreased physiologic reserve and increased vulnerability to health stressors, has an inflammatory biologic basis and has been associated with dysregulation…
2019 American Transplant Congress
Variations in DCD Procurement Procedures across Opos and Their Effects on Liver Transplant Outcomes
A. P. Choubey¹, G. Mitro¹, E. J. Siskind², A. C. Ortiz³, M. Nayebpour⁴, N. Koizumi⁴, P. Wiederhold⁵, J. Ortiz¹
¹The University of Toledo, Toledo, OH, ²Inova Fairfax Hospital, Fairfax, VA, ³University of California, Los Angeles (UCLA), Los Angeles, CA, ⁴George Mason University, Fairfax, VA, ⁵Life Connection Of Ohio, Maumee, OH
*Purpose: Variations in procurement procedures across Organ Procurement Organizations (OPOs) may account for discrepancies in outcomes of donation after cardiac death (DCD) liver transplants. We…
2019 American Transplant Congress
Microscopic Hepatic Steatosis Prior to Liver Transplantation Influences Clinical Outcomes
K. Nakamura, H. Hirao, T. Ito, S. Kageyama, K. Kadono, K. J. Dery, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
Surgery, Liver Transplant, UCLA, Los Angeles, CA
*Purpose: Although liver transplantation (LT) has become a standard care for end-stage liver diseases, early allograft dysfunction (EAD) and rejection crises curtail the outcomes. Considering…
2019 American Transplant Congress
Donor Safety for Minimal Invasive Hepatectoy in Liver Transplantation: The Korean Organ Transplantation Registry
H. Yu, J. Yang, S. Ahn
Chonbuk National University Hospital, Jeonju, Korea, Republic of
*Purpose: This study evaluated the safety and effectiveness of minimal invasive living donor hepatectomy in comparison with conventional open procedure using Korean Organ Transplantation Registry…
2019 American Transplant Congress
Results from the LIVE-C Free Trial
J. N. Fleming¹, D. DuBay¹, N. L. Jonassaint², R. S. Satoskar³, K. D. Chavin⁴
¹Medical University of South Carolina, Charleston, SC, ²University of Pittsburgh Medical Center, Pittsburgh, PA, ³Medstar Georgetown Medical Center, Washington, DC, ⁴University Hospital, Cleveland, OH
*Purpose: Ledipasvir/sofosbuvir (LDV/SOF) in combination with ribavirin (RBV) has shown excellent results post-liver transplant. However, due to the poor tolerability of RBV, it is commonly…
2019 American Transplant Congress
Monitoring And Management Of Proteinuria Is Often Ignored In Patients Receiving mTOR Therapy Following Orthotopic Liver Transplantation
R. Kaur¹, O. Sadiq², M. Alimirah¹, F. Kumssa¹, A. Patel³, S. Jafri²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI, ³Nephrology, Henry Ford Hospital, Detroit, MI
*Purpose: Use of mTOR inhibitors, such as Everolimus (EVL), in liver transplant (LT) patients continues to rise as the side effect profile becomes more evident.…